Cargando…
Drug library screening identifies histone deacetylase inhibition as a novel therapeutic strategy for choriocarcinoma
BACKGROUND: Choriocarcinoma is a rare and aggressive gynecological malignancy. The standard treatment is systemic chemotherapy as choriocarcinoma exhibits high chemosensitivity. However, refractory choriocarcinoma exhibits chemoresistance; thus, the prognosis remains very poor. This study aimed to i...
Autores principales: | Watanabe, Eri, Yokoi, Akira, Yoshida, Kosuke, Sugiyama, Mai, Kitagawa, Masami, Nishino, Kimihiro, Yamamoto, Eiko, Niimi, Kaoru, Yamamoto, Yusuke, Kajiyama, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972027/ https://www.ncbi.nlm.nih.gov/pubmed/36106577 http://dx.doi.org/10.1002/cam4.5243 |
Ejemplares similares
-
A poor prognostic metastatic nongestational choriocarcinoma of the ovary: a case report and the literature review
por: Nishino, Kimihiro, et al.
Publicado: (2021) -
Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model
por: Oda, Yukari, et al.
Publicado: (2023) -
Core 2 β1,6-N-acetylglucosaminyltransferases accelerate the escape of choriocarcinoma from natural killer cell immunity
por: Nakamura, Kenichi, et al.
Publicado: (2021) -
Next-generation genome sequencing of a matched normal-tumor pair from a patient with intractable gestational choriocarcinoma: A case report
por: Niimi, Kaoru, et al.
Publicado: (2021) -
Downregulation of miR‑10b‑5p facilitates the proliferation of uterine leiomyosarcoma cells: A microRNA sequencing‑based approach
por: Yoshida, Kosuke, et al.
Publicado: (2023)